Transient Deficiencies of T-Cell-Mediated Immunity in the Neonate
In summary, neonates demonstrate striking deficiencies in cell-mediated immunity to a number of pathogens. A number of carefully orchestrated cellular and molecular events must occur before a strong cell-mediated immune response can be mounted, and newborns are transiently deficient at a number of points along the way. Neonatal antigen presenting function is less efficient than that of adults, and, in particular neonatal dendritic cells secrete less IL-12. Neonatal CD4 cells are prevented from differentiating into Th1 cells due to decreased levels of STAT4 and epigenetic regulation of the IFN-γ promoter. They also express less CD154. Consequently, the normal positive feedback loops for driving cell-mediated immunity, in which IFN-γ and CD154 from T cells induce dendritic cells to produce more IL-12, are interrupted. A better understanding of these mechanisms will be important in the care of newborns as well as in vaccine development.
KeywordsDendritic Cell Herpes Simplex Virus Infection Congenital Infection Myeloid Dendritic Cell Adult Peripheral Blood
Unable to display preview. Download preview PDF.
- Gasparoni, A., Ciardelli, L., Avanzini, A., Castellazzi, A.M., Carini, R., Rondini, G., and Chirico, G. (2003). Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol. Neonate 84, 297–303.PubMedCrossRefGoogle Scholar
- Guerina, N.G., Hsu, H.W., Meissner, H.C., Maguire, J.H., Lynfield, R., Stechenberg, B., Abroms, I., Pasternack, M.S., Hoff, R., and Eaton, R.B., et al. (1994). Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N. Engl. J. Med. 330, 1858–1863.PubMedCrossRefGoogle Scholar
- Peggs, K.S., Verfuerth, S., Pizzey, A., Khan, N., Moss, P., and Goldstone, A.H., et al. (2003). Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection. Biol. Blood Marrow Transplant. 9, 198–205.PubMedCrossRefGoogle Scholar
- Pirenne-Ansart, H., Paillard, F., De Groote, D., Eljaafari, A., Le Gac, S., Blot, P., Franchimont, P., Vaquero, C., and Sterkers, G. (1995). Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3-or CD2-activated T cells from neonates. Pediatr. Res. 37, 64–69.PubMedGoogle Scholar
- Subauste, C.S., Wessendarp, M., Sorensen, R.U., and Leiva, L.E. (1999). CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J. Immunol. 162, 6690–6700.PubMedGoogle Scholar
- Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., and Riddell, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038–1044.PubMedCrossRefGoogle Scholar